- Home
- NTZ vs ACHL Comparison
NTZ vs ACHL Comparison
Compare NTZ & ACHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTZ
- ACHL
- Stock Information
- Founded
- NTZ 1959
- ACHL 2016
- Country
- NTZ Italy
- ACHL United Kingdom
- Employees
- NTZ N/A
- ACHL N/A
- Industry
- NTZ Home Furnishings
- ACHL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NTZ Consumer Discretionary
- ACHL Health Care
- Exchange
- NTZ Nasdaq
- ACHL Nasdaq
- Market Cap
- NTZ 45.4M
- ACHL 43.6M
- IPO Year
- NTZ 1993
- ACHL 2021
- Fundamental
- Price
- NTZ $4.15
- ACHL $0.95
- Analyst Decision
- NTZ
- ACHL Buy
- Analyst Count
- NTZ 0
- ACHL 2
- Target Price
- NTZ N/A
- ACHL $4.00
- AVG Volume (30 Days)
- NTZ 3.4K
- ACHL 107.8K
- Earning Date
- NTZ 12-12-2024
- ACHL 11-14-2024
- Dividend Yield
- NTZ N/A
- ACHL N/A
- EPS Growth
- NTZ N/A
- ACHL N/A
- EPS
- NTZ N/A
- ACHL N/A
- Revenue
- NTZ $365,846,531.00
- ACHL N/A
- Revenue This Year
- NTZ N/A
- ACHL N/A
- Revenue Next Year
- NTZ N/A
- ACHL N/A
- P/E Ratio
- NTZ N/A
- ACHL N/A
- Revenue Growth
- NTZ N/A
- ACHL N/A
- 52 Week Low
- NTZ $3.80
- ACHL $0.63
- 52 Week High
- NTZ $7.20
- ACHL $1.76
- Technical
- Relative Strength Index (RSI)
- NTZ 40.50
- ACHL 29.24
- Support Level
- NTZ $3.85
- ACHL $0.97
- Resistance Level
- NTZ $4.45
- ACHL $1.01
- Average True Range (ATR)
- NTZ 0.23
- ACHL 0.03
- MACD
- NTZ -0.08
- ACHL -0.01
- Stochastic Oscillator
- NTZ 18.18
- ACHL 0.87
About NTZ Natuzzi S.p.A.
Natuzzi SpA is an Italian firm that designs, manufactures, and sells contemporary and traditional leather and fabric-upholstered furniture. Its product portfolio including sofas, loveseats, armchairs, sectional furniture, motion furniture and sofa beds, living room furnishings, and accessories. The company markets its products under several brands such as Natuzzi Italia, Private label, and Natuzzi Editions. Geographically, it derives a majority of revenue from the United States of America and also has an international presence in Italy, Spain, UK and Other countries.
About ACHL Achilles Therapeutics plc
Achilles Therapeutics PLC is a biopharmaceutical company. It is developing AI-powered precision T-cell therapies targeting clonal neoantigens to treat solid tumors. The company has two ongoing trials, the CHIRON trial in patients with non-small-cell lung cancer and the THETIS trial in patients with recurrent or metastatic melanoma.